Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IACH MATH 2020 | Management of chronic GvHD

Zinaida Perić • 25 Jun 2020
IACH MATH 2020
General Ibrutinib

Zinaida Perić, MD, PhD, University Hospital Centre Zagreb, School of Medicine, Zagreb, Croatia, discusses the management of chronic graft-versus-host disease (GvHD) and what is on the horizon for patients. Dr Perić highlights the need for a multidisciplinary approach to chronic GvHD management as well as the importance of regular evaluations. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Zinaida Perić

2:34
Advances in chronic GvHD management
Zinaida Perić • 28 Sep 2021
2:56
Ibrutinib, ruxolitinib & belumosudil for SR-cGvHD
Zinaida Perić • 28 Sep 2021
2:13
Next steps in chronic GvHD
Zinaida Perić • 28 Sep 2021
6:02
Amniotic membrane transplantation in ocular GvHD
Zinaida Perić • 25 Jun 2020

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals